InsidersTradesSigma
申报总数
公司
▲ 买入（2 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
2
已披露卖出
0
T+90 胜率
0%
T+90 平均收益
-59.6%
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Explore the complete record of transactions filed by Watts Charles M, 董事. Director active across 2 companies, notably BIODESIX INC. Aggregated, 8 reports have been recorded. Breakdown: 2 buys · 0 sell. Total volume traded: €71k. History available since 20 December 2021. The latest transaction was filed on 3 August 2023 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Watts Charles M
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报8 总计
46,686 股Common StockSEC:0000905148-25-001048:0
26,368 股Common StockSEC:0000905148-24-001920:0
134,262 股Common StockSEC:0000905148-24-001076:0
12,345 股@ US$1.6216.4% 占其流量Common StockSEC:0000905148-23-000630:0
69,619 股0Common StockSEC:0001628280-23-019989:0
150,711 股Common StockSEC:0001140361-23-016257:0
43,478 股@ US$1.1543.5% 占其流量Common StockSEC:0001140361-22-042603:0
标准退出：2023年2月19日 (T+90)
5,855 股@ US$4.292425.1% 占其流量Common StockSEC:0001567619-21-022443:0
标准退出：2022年3月20日 (T+90)
8 条申报中的 8 条
About Watts Charles M
Watts Charles M is a Director and has filed 8 transactions in total. Across the 8 filings we hold, they span from 2021-12-22 to 2025-04-02, with EUR 70751 of purchases and EUR 0 of sales, and the most common transaction type is option exercise. The filings relate to BIODESIX INC and Accelerate Diagnostics, Inc, and the largest published filings are 2022-11-21 for EUR 48398.20924886679 and 2021-12-22 for EUR 22352.40017807916, both at BIODESIX INC.
